Translational Development... (TDACU)
NASDAQ: TDACU
· Real-Time Price · USD
10.28
0.00 (0.00%)
At close: Jun 12, 2025, 3:37 PM
10.28
0.00%
After-hours: Jun 12, 2025, 04:00 PM EDT
Company Description
Trident Acquisitions Corp. is a shell company.
The Company is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses or entities.
The Company focuses on identifying a business to a particular industry or geographic region of the world.
The Company is focused on seeking business combination with oil and gas or other natural resources companies in Eastern Europe.
The Company is not engaged in any business operations.
Translational Development Acquisition Corp.
| Country | United States |
| IPO Date | Jan 31, 2022 |
| Industry | Shell Companies |
| Sector | Financial Services |
| Employees | n/a |
| CEO | Michael M. B. Hoffman J.D. |
Contact Details
Address: 77 Water Street New York City, New York United States | |
| Website | http://www.tridentacquisitions.com |
Stock Details
| Ticker Symbol | TDACU |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | 0001673481 |
| CUSIP Number | 89615T205 |
| ISIN Number | US89615T2050 |
| Employer ID | 81-1996183 |
| SIC Code | 7372 |
Key Executives
| Name | Position |
|---|---|
| Michael M. B. Hoffman J.D. | Chairman of the Board & Chief Executive Officer |
| Avi C. Das | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 10, 2025 | 8-K | Current Report |
| Jun 06, 2025 | 8-K | Current Report |
| May 23, 2025 | 8-K | Current Report |
| May 21, 2025 | 10-Q | Quarterly Report |
| May 16, 2025 | NT 10-Q | Filing |
| May 15, 2025 | 10-Q | Quarterly Report |
| May 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| May 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| May 14, 2025 | S-1/A | [Amend] Filing |
| May 13, 2025 | 8-K | Current Report |